News
More phase 3 data support use of nemolizumab for prurigo nodularis
"Now I hope you understand why we are so excited," said lead investigator Sonja Ständer, MD.
News
Birch bark–derived treatment reduces daily dressings in patients with epidermolysis bullosa
Despite being approved in Europe, Oleogel-S10 has not yet been approved to treat EB in the United States.
News
Roflumilast side effect benefits patients with psoriasis and overweight/obesity
An “extraordinary” finding was how some patients’ weight status based on their BMI changed throughout the study.
News
Topical botanical drug coacillium curbs childhood alopecia
Coacillium cutaneous solution is also under investigation as a treatment for persistent chemotherapy-induced alopecia, atopic dermatitis, and...
News
Axial spondyloarthritis: Does visibility with x-rays make a difference in management?
“Axial spondyloarthritis is one disease, and whether it is radiographic or nonradiographic makes zero difference in the management of the patient...
News
Diagnosing chronic back pain: When to suspect axial spondyloarthritis
Worldwide, the average time to diagnosis was found to be up to 6 years, but patient advocacy groups say the delay can be up to 10 years or more....
News
Enthesitis, arthritis, tenosynovitis linked to dupilumab use for atopic dermatitis
Musculoskeletal symptoms identified in some patients treated with dupilumab for atopic dermatitis could help further understanding of how...
News
Low disease state for childhood lupus approaches validation
A new childhood version of the Lupus Low Disease Activity State has been purposefully developed to align with the criteria already used for adults...
News
Normal CRP during RA flares: An ‘underappreciated, persistent phenotype’
In about 5% of patients with seropositive RA, C-reactive protein levels were normal despite disease flares during a 5-year period. The findings...
News
Long-COVID rate may be higher with rheumatic diseases
The results highlight the need for close monitoring and optimized multidisciplinary care for long-term adverse events after COVID-19 in patients...
News
NSAID use may mask MRI findings in a quarter of spondyloarthritis cases
Among nearly one in four patients whose MRI results were initially positive for sacroiliitis, results were negative 6 weeks after NSAIDs were...
News
Meta-analysis examines cancer risk concern for JAK inhibitors
Although no increased cancer risk was seen vs. methotrexate or placebo, Janus kinase inhibitors were associated with a higher cancer risk than...
News
Registry data ‘reassure’ on biologics’ heart attack risk in rheumatoid arthritis
There is no difference in the risk of myocardial infarction with interleukin-6 (IL-6) vs. anti–tumor necrosis factor (TNF) therapy for rheumatoid...
News
Cardiovascular risk score multipliers suggested for rheumatic diseases
Guidelines could tailor cardiovascular risk scores by using a multiplier of 2.5 for systemic sclerosis, 2.0 for lupus, and 1.5 for any other...
News
RA risk raised by work-related inhaled agents
Exposure to detergents, dusts, and other chemicals in the workplace could be putting genetically susceptible people at risk of rheumatoid...